美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ra Pharmaceuticals Inc.

48.00

0.0000

成交量：- -

成交額：- -

市值：22.72億

市盈率：-20.73

高：48.00

開：48.00

低：48.00

收：48.00

52周最高：48.02

52周最低：19.64

股本：4,732.89萬

流通股本：3,590.33萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.3147

每股收益(LYR):-2.3147

淨資產收益率：-43.77%

總資產收益率：-26.57%

市淨率：8.67

市盈率(LYR):-20.73

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Ra Pharmaceuticals Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.rapharma.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Ra Pharmaceuticals, Inc.在特拉華州註冊成立於2008年6月27日。Ra Pharmaceuticals，Inc.是一家臨床階段生物製藥公司，利用其專有的肽化學平台創造新型治療劑，治療由補體系統的過度和不受控制的激活引起的疾病，補體系統是身體先天免疫系統的必需成分。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/RARX/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RARX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RARX\",,,,,undefined,":{"symbol":"RARX","market":"US","secType":"STK","nameCN":"Ra Pharmaceuticals Inc.","latestPrice":47.995,"timestamp":1585771200000,"preClose":47.995,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":35903343,"shares":47328875,"eps":-2.314721,"marketStatus":"停牌","change":0,"latestTime":"04-01 16:00:00 EDT","open":47.995,"high":47.995,"low":47.995,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.314721,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1477454400000,"exchange":"NASDAQ","adjPreClose":47.995,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RARX\",,,,,undefined,":{"symbol":"RARX","floatShares":35903343,"roa":"-26.57%","roe":"-43.77%","lyrEps":-2.314721,"shares":47328875,"dividePrice":0,"high":47.995,"amplitude":0,"preClose":47.995,"low":47.995,"week52Low":19.64,"pbRate":"8.67","week52High":48.02,"institutionHeld":0,"latestPrice":47.995,"eps":-2.314721,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.314721,"open":47.995,"prevYearClose":46.93},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RARX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-08-07","symbol":"RARX","fiscalQuarterEnding":"2019/06","expectedEps":-0.48,"name":null,"time":"","type":"earning","dateTimestamp":1565150400000,"reportTimeType":"","actualEps":-0.52},{"market":"US","date":"2019-05-09","symbol":"RARX","fiscalQuarterEnding":"2019/03","expectedEps":-0.49,"name":null,"time":"","type":"earning","dateTimestamp":1557374400000,"reportTimeType":"","actualEps":-0.45},{"market":"US","date":"2019-03-07","symbol":"RARX","fiscalQuarterEnding":"2018/12","expectedEps":-0.52,"name":null,"time":"","type":"earning","dateTimestamp":1551934800000,"reportTimeType":"","actualEps":-0.47},{"market":"US","date":"2018-11-07","symbol":"RARX","fiscalQuarterEnding":"2018/09","expectedEps":-0.52,"name":null,"time":"","type":"earning","dateTimestamp":1541566800000,"reportTimeType":"","actualEps":-0.51},{"market":"US","date":"2018-08-08","symbol":"RARX","fiscalQuarterEnding":"2018/06","expectedEps":-0.56,"name":null,"time":"","type":"earning","dateTimestamp":1533700800000,"reportTimeType":"","actualEps":-0.49}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RARX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RARX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.rapharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Ra Pharmaceuticals, Inc.在特拉華州註冊成立於2008年6月27日。Ra Pharmaceuticals，Inc.是一家臨床階段生物製藥公司，利用其專有的肽化學平台創造新型治療劑，治療由補體系統的過度和不受控制的激活引起的疾病，補體系統是身體先天免疫系統的必需成分。","exchange":"NASDAQ","name":"Ra Pharmaceuticals Inc.","nameEN":"Ra Pharmaceuticals Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"RARX\",market:\"US\",,,undefined,":null}}